The following table summarizes the computation of basic and diluted net loss per share of the Company for the years ended December 31, 2023 and December 31, 2022 (in thousands, except per share data):


	Year Ended December 31,
	2023		2022
Net loss	$	(112,673)	$	(133,204)
Weighted-average common stock outstanding, basic and diluted	57,744		56,201
Net loss per share, basic and diluted	$	(1.95)	$	(2.37)

The Company’s potentially dilutive securities, which include options to purchase shares of the Company's common stock and restricted stock awards subject to future vesting, have been excluded from the computation of diluted net loss per share as the effect would be to reduce the net loss per share.

The Company excluded the following potential shares of common stock, presented based on amounts outstanding at each stated period end, from the computation of diluted net loss per share for the periods indicated because including them would have had an anti-dilutive effect (in thousands):


	Year Ended December 31,
	2023	2022
Stock options to purchase common stock	8,197	7,151
Early exercised stock options subject to future vesting	56	304
Restricted stock units subject to future vesting	1,635	2,243
Restricted stock awards subject to future vesting	20	54

Total	9,908	9,752

In addition to the potentially dilutive securities noted above, the Company also has the option under its agreement with Tempus to issue common shares upon the achievement of specified milestones. Please refer to Note 8, “Commitment and Contingencies - Amended Tempus Research and Development Agreement” section for

further details. Because the necessary conditions for issuance of the shares had not been met as of December 31, 2023, the Company excluded these shares from the table above.